Concentrix (CNXC) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
9 Jul, 2026Executive summary
Achieved sequential revenue growth each quarter in 2025, exceeding guidance and delivering $9.83B in revenue, with a three-year CAGR of 15.8% driven by demand for intelligent transformation solutions.
Focused on evolving to a high-value, technology-enabled transformation partner, investing in AI, automation, and expanding service offerings, with CEO highlighting successful AI-powered solutions and favorable growth outlook.
Drove significant operational efficiencies, reducing non-billable costs by $100 million and shifting 4% of onshore business offshore.
Returned $258 million to shareholders and reduced net debt by $184 million.
Fiscal 2025 included a non-cash goodwill impairment charge of $1,523.3 million, resulting in a net loss for the year.
Financial highlights
Q4 2025 revenue was $2.55 billion, up 4.3% year-over-year and 3.1% constant currency; full-year revenue was $9.83 billion, up 2.2%.
Q4 non-GAAP operating income: $323.2 million (12.7% margin); adjusted EBITDA: $378.6 million (14.8% margin); non-GAAP net income: $192 million; non-GAAP EPS: $2.95.
Full-year non-GAAP operating income: $1.254 billion (12.8% margin); adjusted free cash flow: $626 million, up 32% year-over-year.
Q4 GAAP net loss due to $1.52 billion non-cash goodwill impairment charge.
Net debt reduced by $184 million year-over-year to $4.31 billion.
Outlook and guidance
FY 2026 revenue guidance: $10.035–$10.18 billion, representing 1.5–3% constant currency growth.
Full-year non-GAAP operating income expected at $1.24–$1.29 billion; non-GAAP EPS: $11.48–$12.07.
Adjusted free cash flow expected to rise to $630–$650 million in 2026.
Q1 2026 revenue guidance: $2.475–$2.5 billion; non-GAAP operating income: $290–$300 million; non-GAAP EPS: $2.57–$2.69.
Sequential margin improvement expected in the second half of 2026 as duplicate costs are removed.
Latest events from Concentrix
- AI-driven IX suite accelerates margin growth and cash flow, supporting debt reduction and future value.CNXC
Canaccord Genuity's 46th Annual Growth Conference - Q2 revenue up 1.9% with record cash flow, but margins fell amid restructuring costs.CNXC
Q2 2026 - All voting items, including director elections and stock plan amendment, were approved.CNXC
AGM 2026 - Revenue up 5.4% to $2.5B, but margins and net income declined despite strong AI-driven growth.CNXC
Q1 2026 - Supplement clarifies voting rules for a key stock incentive plan amendment proposal.CNXC
Proxy Filing - Key votes include director elections, auditor ratification, and stock plan amendment.CNXC
Proxy Filing - 2026 meeting covers board elections, auditor, pay, and equity plan amid strong governance and ESG.CNXC
Proxy Filing - Q2 revenue up 47.4% to $2.38B; guidance raised despite net income decline on higher costs.CNXC
Q2 2024 - FY25 guidance projects modest revenue growth, margin expansion, and higher free cash flow.CNXC
Q4 2024